Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Zydus launches the world s first biosimilar of Nivolumab, Tishtha , in India to treat multiple cancers".
Press Release Jan 22 2026
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 15 2026
- Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
- Press Release Jan 13 2026
- Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
- Press Release Dec 23 2025
Later from Zydus Lifesciences
- Press Release Jan 23 2026
- Press Release Feb 04 2026
- Press Release Feb 06 2026
- Press Release Feb 09 2026
- Press Release 10-02-2026 NewspaperPublication10022026
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences